Purigen Biosystems
Innovative products that offer a truly transformative automated solution for DNA and RNA purification.
Launch date
Employees
Market cap
-
Enterprise valuation
€125—188m (Dealroom.co estimates Apr 2021.)
Pleasanton California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $830k | Debt | |
N/A | $200k | Debt | |
N/A | $13.0m | Late VC | |
$18.2m | Series A | ||
$26.4m | Series B | ||
N/A | $34.4m | Late VC | |
* | $32.0m | Acquisition | |
Total Funding | €83.6m |
Related Content
Recent News about Purigen Biosystems
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.